Prognostic significance of the combined use of preoperative platelet count and serum carcinoembryonic antigen level in non-small-cell lung cancer

被引:33
作者
Tomita M. [1 ]
Shimizu T. [1 ]
Ayabe T. [1 ]
Onitsuka T. [1 ]
机构
[1] Department of Surgery II, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1692, 5200 Kihara, Kiyotake
关键词
Carcinoembryonic antigen; Non-small-cell lung cancer; Prognosis; Thrombocytosis;
D O I
10.1007/s11748-010-0647-2
中图分类号
学科分类号
摘要
Purpose: The prognostic significance of the combined use of preoperative platelet count and serum carcinoembryonic antigen (CEA) level in non-small-cell lung cancer patients was investigated. Methods: Consecutive 289 non-small-cell lung cancer patients were reviewed retrospectively. Thrombocytosis was defined as a platelet count of at least 40 × 104/mm3. Results: The frequency of preoperative thrombocytosis was 4.5% (13/289). The 5-year survival of patients with thrombocytosis was 30.77%, which was significantly poorer than that of patients with normal counts (68.65%, P = 0.0010). The 5-year survivals of patients with a normal CEA level and those with an elevated serum CEA level were 74.18% and 55.78%, respectively (P = 0.0019). Patients with both a normal platelet count and a normal serum CEA level had a favorable prognosis, whereas those with both thrombocytosis and elevated serum CEA level had a poor prognosis. The prognostic impact of the combined use of the platelet count and the serum CEA level was more significant than that of the platelet count or the serum CEA level alone. Both univariate and multivariate analyses indicated an independent prognostic impact of the combined use of platelet count and serum CEA levels. Conclusion: The combined use of preoperative platelet count and serum CEA levels might be useful for predicting the prognosis of non-small-cell lung cancer patients. © 2010 The Japanese Association for Thoracic Surgery.
引用
收藏
页码:573 / 576
页数:3
相关论文
共 14 条
[1]
Costantini V., Zacharski L.R., Moritz T.E., Edwards R.L., The platelet count in carcinoma of the lung and colon, Thromb Haemost, 64, pp. 501-505, (1990)
[2]
Gislason T., Nou E., Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: An epidemiological study, Eur J Respir Dis, 66, pp. 141-146, (1985)
[3]
Engan T., Hannisdal E., Blood analyses as prognostic factors in primary lung cancer, Acta Oncol, 29, pp. 151-154, (1990)
[4]
Moller Pedersen L., Milman N., Prognostic significance of thrombocytosis in patients with primary lung cancer, European Respiratory Journal, 9, 9, pp. 1826-1830, (1996)
[5]
Aoe K., Hiraki A., Ueoka H., Kiura K., Tabata M., Tanaka M., Tanimoto M., Thrombocytosis as a useful prognostic indicator in patients with lung cancer, Respiration, 71, 2, pp. 170-173, (2004)
[6]
Tomita M., Shimizu T., Hara M., Ayabe T., Onitsuka T., Prognostic impact of thrombocytosis in resectable non-small cell lung cancer, Interact Cardiovasc Thorac Surg, 7, pp. 613-615, (2008)
[7]
Icard P., Regnard J.F., Essomba A., Panebianco V., Magdeleinat P., Levasseur P., Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer, Ann Thorac Surg, 58, pp. 811-814, (1994)
[8]
Rubins J.B., Dunitz J., Rubins H.B., Maddaus M.A., Niewoehner D.E., Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer, J Thorac Cardiovasc Surg, 116, pp. 412-416, (1998)
[9]
Tomita M., Matsuzaki Y., Edagawa M., Shimizu T., Hara M., Onitsuka T., Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma, Ann Thorac Cardiovasc Surg, 10, pp. 76-80, (2004)
[10]
Okada M., Nishio W., Sakamoto T., Uchino K., Yuki T., Nakagawa A., Tsubota N., Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: Analysis of 1,000 consecutive resections for clinical stage I disease, Annals of Thoracic Surgery, 78, 1, pp. 216-221, (2004)